Year archive

Novartis India Limited. — 2024 filings

All 127 regulatory filings released by Novartis India Limited. (NOVARTIND) in 2024, sourced directly from the official regulator.

127 Filings

2024 Period

2024 filings (127)

Filing	Released	Lang
NOVARTIS INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/01/2025 ,inter alia, to consider and approve The intimation is filed to .... Regulatory Filings	2024-12-27	English
The Board Meeting of the Company for the approval of unaudited financial results for the quarter ended as on Dec 31, 2024 shall be convened on Tuesday, January 28, 2025. The Trading window .... Regulatory Filings	2024-12-27	English
Intimation under regulation 39(3) of SEBI LODR Regulation, received from the RTA of the company on December 25, 2024 for loss of share certificate by the shareholder of the company. Regulatory Filings	2024-12-27	English
Filing of intimation as received from RTA for the loss of share certificate by the shareholder dated December 05, 2024 under Reg 39(3) of SEBI LODR 2015 Regulatory Filings	2024-12-05	English
Intimation under regulation 39(3) for issue of duplicate share certificate received from the company''s RTA dated December 03 2024. Regulatory Filings	2024-12-04	English
Filing of Intimation under Reg 39(3) of SEBI LODR 2015 as received from Company`s RTA for providing the information about the loss of share certificate by the shareholder as of November 28, 2024. Regulatory Filings	2024-11-28	English
The intimation is filed under Reg 39(3) of SEBI LODR as per the information received from the company`s RTA for the loss of share certificate by the shareholder as on November 20, 2024. Regulatory Filings	2024-11-21	English
Filing of Intimation under Reg 39(3) of SEBI LODR 2015 received from RTA of the Company providing the information regarding the issue of Duplicate Share Certificate to shareholders as of .... Regulatory Filings	2024-11-20	English
Filing of Intimation r/r 39(3) received from Company''s RTA for loss of share certificates dated November 15, 2024 Regulatory Filings	2024-11-15	English
Filing of Intimation received from Company`s RTA for the loss of share certificate by the shareholder as on November 14, 2024 under reg 39(3) of SEBI LODR Regulatory Filings	2024-11-14	English
Filing the intimation received from Company`s RTA for the issue of Duplicate Share certificate to the Shareholder on account of loss of share certificate as on November 13, 2024 Regulatory Filings	2024-11-14	English
Filing of Intimation received from Company RTA in relation to the Loss of Share Certificates by the Shareholder as on November 13, 2024, under Reg 39(3) of SEBI LODR 2015. Regulatory Filings	2024-11-14	English
Filing of intimation regarding the publication of financial results for the Quarter and Half year ended September 30, 2024 in newspapers i.e Financial express and Navshakti on October 26, 2024 Regulatory Filings	2024-10-28	English
Filing of the outcome of Board Meeting and Unaudited Financial Results for the quarter and half year ended September 30, 2024 Regulatory Filings	2024-10-25	English
Filing of intimation for issue of duplicate share certificates received from the Company''s RTA dated October 23, 2024 Regulatory Filings	2024-10-24	English
Filing of Intimation for loss of share certificates received from Company''s RTA dated October 23, 2024 Regulatory Filings	2024-10-24	English
Filing of Certificate dated 03.10.2024 under regulation 74(5) received from the Companys'' RTA for the quarter ended Sept 30, 2024 Regulatory Filings	2024-10-11	English
Intimation for re-issue of share certificate received from Company''s RTA dated 08.10.2024 Regulatory Filings	2024-10-09	English
Filing of Intimation u/r 39(3) for the loss of share certificates received from Company''s RTA dated September 28, 2024 Regulatory Filings	2024-09-30	English
NOVARTIS INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/10/2024 ,inter alia, to consider and approve the Unaudited Financial Results .... Regulatory Filings	2024-09-27	English
Intimation for the closure of Trading Window for the quarter ended September 30, 2024. The trading window will be closed from October 01, 2024. The trading window will open 48 hours after .... Regulatory Filings	2024-09-27	English
Filing of clarification on the email received from BSE dated September 26, 2024, on the rumor in relation to acquisition of Novartis India Limited from its Swiss Parent Company by Alkem Labs. Regulatory Filings	2024-09-26	English
Filing of intimation u/r 39(3) for the loss of share certificate received from Company''s RTA dated September 26, 2024 Regulatory Filings	2024-09-26	English
The Company Novartis India Limited has been importing DESFERAL (deforoxamine) from Novartis Pharma AG and selling it in India. This intimation is filed to inform that DESFERAL (deforoxamine) .... Regulatory Filings	2024-09-25	English
Filing of intimation u/r 39(3) for loss of share certificate received from Companys'' RTA dated September 22, 2024. Regulatory Filings	2024-09-23	English
Filing of intimation u/r 39(3) for loss of share certificates received from the Companys'' RTA dated September 12, 2024. Regulatory Filings	2024-09-12	English
Filing of intimation u/r 39(3) for Issues of Duplicate Share Certificates received from the Companys'' RTA dated September 11, 2024 Regulatory Filings	2024-09-12	English
Filing of intimation received from RTA for the loss of share certificate u/r 39(3) dated September 07, 2024 Regulatory Filings	2024-09-09	English
Filing of Intimation received from Company`s Registrar and Share Transfer Agent under Regulation 39(3) of the SEBI LODR regulations for the Loss of Share Certificate by the shareholders .... Regulatory Filings	2024-09-02	English
Filing of intimation received from RTA for the loss of share certificate u/r 39(3) dated 30th August, 2024 Regulatory Filings	2024-08-30	English
Filing of intimation received from RTA for the loss of share certificate u/r 39(3) dated 29th August, 2024 Regulatory Filings	2024-08-29	English
Filing of Intimation received from RTA for the loss of share certificate u/r. 39(3) dated 24th August, 2024. Regulatory Filings	2024-08-26	English
Filing of intimation for the issue of duplicate share certificate as per the letter received from RTA dated 19.08.2024 Regulatory Filings	2024-08-20	English
Filing of intimation for loss of Share Certificate as received from RTA dated 15.08.2024 u/r. 39(3) Regulatory Filings	2024-08-16	English
Filing of intimation received from RTA for the Loss of share certificate by the Shareholder as of August 09 2024. Regulatory Filings	2024-08-11	English
Filing the intimation received from Registrar and Share Transfer Agent on the loss of Share Certificate dated August 03, 2024. Regulatory Filings	2024-08-05	English
Intimation under regulation 39(3) of SEBI (LODR) Regulations, 2015 regarding loss of share certificates. Regulatory Filings	2024-08-02	English
Filing of Voting Results and Scrutinizers Report for the 76th Annual General Meeting of Novartis India Limited held on July 31, 2024 Regulatory Filings	2024-08-01	English
Outcome of Annual General Meeting held on July 31, 2024 of Novartis India Limited AGM Information	2024-07-31	English
Intimation of Newspaper Advertisement regarding publication of Unaudited Financial results for First Quarter ended June 30, 2024. Regulatory Filings	2024-07-30	English
Results - Unaudited Financial Results for the first Quarter ended June 30, 2024. Regulatory Filings	2024-07-29	English
Outcome - Unaudited Financial Results for the Quarter ended June 30, 2024 Regulatory Filings	2024-07-29	English
Intimation regarding issue of Duplicate Share Certificate issued by Company as per the letter received from RTA dated July 22, 2024 Regulatory Filings	2024-07-25	English
Compliance - Certificate under Reg 74(5) of SEBI (DP) Regulations 2018. Regulatory Filings	2024-07-12	English
Intimation regarding the Record date for declaration of Dividend for F.Y 2023-24. Notice of Dividend Amount	2024-07-11	English
Annual Report pursuant to the intimation of Corrigendum to the Notice of 76th Annual General Meeting. Regulatory Filings	2024-07-10	English
Intimation regarding Corrigendum to the Notice of 76th Annual General Meeting. Regulatory Filings	2024-07-10	English
Intimation under SEBI (LODR)2015, regarding Post Newspaper advertisement for completion of sending of Notice of AGM along with Annual report for FY 2023-2024. Report Publication Announcement	2024-07-08	English
Filing of Intimation received from RTA regarding the loss of certificate by the shareholder. Regulatory Filings	2024-07-06	English
Communication to Members of the Company - Intimation on tax deduction on dividend for the financial year 2023-24 if declared at the ensuing Annual General Meeting to be held on July 31, 2024. Notice of Dividend Amount	2024-07-05	English
Business Responsibility and Sustainability Reporting for the Financial year ended March 31, 2024 of Novartis India Limited Environmental & Social Information	2024-07-05	English
Filing of Annual Report of Novartis India Limited Regulatory Filings	2024-07-05	English
Notice convening the 76th Annual General Meeting of Novartis India Limited to be held on July 31, 2024 Regulatory Filings	2024-07-05	English
Intimation regarding pre-issue of Notice of AGM in Newspaper AGM Information	2024-07-04	English
Intimation under regulation 39(3) of SEBI (LODR), 2015 for loss of share certificates. Regulatory Filings	2024-07-04	English
Intimation under regulation 39(3) of SEBI (LODR), 2015 for loss of share certificates. Regulatory Filings	2024-07-04	English
Filing of intimation regarding the loss of certificate by the shareholder as received from RTA dated June 29 2024 under the SEBI LODR. Regulatory Filings	2024-06-29	English
Announcement under regulation 30 of SEBI LODR for the appointment of Additional Director (designated as Whole Time Director) subject to the approval of members. The Board of Directors approved .... Board/Management Information	2024-06-28	English
Board Meeting outcome for meeting of Board of Directors of Novartis India Limited held on June 28, 2024 for appointment of additional Director (designated as Whole Time Director) Board/Management Information	2024-06-28	English
Intimation in relation to Board meeting and closure of Trading window for period July 01, 2024 to July 31, 2024 Regulatory Filings	2024-06-27	English
Intimation in relation to issue of Duplicate Share Certificate as per regulation 39(3) of SEBI LODR Regulations 2015. Regulatory Filings	2024-06-25	English
Intimation regarding loss of share certificates under regulation 39(3) of SEBI (LODR) Regulations, 2015 Regulatory Filings	2024-06-18	English
Intimation regarding loss of Share certificate under Regulation 39(3) of SEBI LODR Regulations. Regulatory Filings	2024-06-17	English
Intimation regarding the issue of Duplicate Share certificate under Reg 39 (3) of SEBI LODR Regulations. Regulatory Filings	2024-06-14	English
Intimation under SEBI (LODR) regulation 39(3) for loss of share certificate Regulatory Filings	2024-06-12	English
Announcement regarding transfer of shares to Investor Education and Protection Fund (IEPF) Regulatory Filings	2024-06-12	English
This intimation is filed pursuant to Reg 39 (3) for the issue of duplicate share certificate. The intimation is received as on May 28, 2024 from RTA to the Company. Regulatory Filings	2024-05-29	English
Compliances for filing the Annual Secretarial Compliance report under regulation 24(A) of SEBI LODR. Regulatory Filings	2024-05-24	English
Intimation under regulation 39(3) of SEBI (LODR) Regulation, 2015 regarding issue of Duplicate share certificates Regulatory Filings	2024-05-24	English
Intimation under regulation 39(3) of SEBI (LODR) Regulations, 2015 for loss of share certificate Regulatory Filings	2024-05-24	English
Intimation under regulation 39(3) of SEBI(LODR) Regulations, 2015 for loss of share certificates Regulatory Filings	2024-05-24	English
Intimation regarding loss of share certificate under regulation 39(3)of SEBI (LODR) Regulations, 2015 Regulatory Filings	2024-05-17	English
Intimation regarding Loss of share certificate under regulation 39(3) of SEBI (LODR) Regulations, 2015 Regulatory Filings	2024-05-15	English
Intimation under Regulation 39(3) of SEBI (LODR) Regulations 2015 regarding issue of Duplicate share certificate Regulatory Filings	2024-05-14	English
Announcement under Regulation 30 (LODR)- Newspaper Publication in relation to Financial Results for year ending March 31, 2024 published in newspapers. Interim / Quarterly Report FY 2024	2024-05-13	English
Corporate Action - fixes book closure Regulatory Filings	2024-05-10	English
Corporate Action - Board approved dividend Regulatory Filings	2024-05-10	English
Results for the quarter and year ended March 31, 2024 Regulatory Filings	2024-05-10	English
Outcome of the Meeting of the Board of Directors of Novartis India Limited ('the Company') held on May 10, 2024 Regulatory Filings	2024-05-10	English
Approval for the appointment of Company Secretary and Compliance officer by Novartis India Limited. Board/Management Information	2024-05-08	English
Disclosure regarding the authorizing the Company Secretary and Compliance officer subsequent to her appointment for determining the materiality of events or information Board/Management Information	2024-05-08	English
Appointment of Company Secretary and Compliance officer in Novartis India Limited. Board/Management Information	2024-05-08	English
The Resolution is passed approving the appointment of Company Secretary and Compliance officer of Novartis India Limited. Board/Management Information	2024-05-08	English
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details .... Regulatory Filings	2024-04-25	English
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Regulatory Filings	2024-04-25	English
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Regulatory Filings	2024-04-20	English
Compliances - Reg. 40(10) - PCS Certificate for Transfer / Transmission / Transposition Regulatory Filings	2024-04-15	English
Certificate under Regulation 7(3) of SEBI (LODR) Regulations, 2015 Regulatory Filings	2024-04-10	English
Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018 Regulatory Filings	2024-04-08	English
Resignation of Company Secretary / Compliance Officer Board/Management Information	2024-04-01	English
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Regulatory Filings	2024-03-30	English
Newspaper Publication - Notice of meeting of the Board of Directors Regulatory Filings	2024-03-28	English
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Regulatory Filings	2024-03-28	English
Closure of Trading Window Regulatory Filings	2024-03-27	English
NOVARTIS INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/05/2024 ,inter alia, to consider and approve the Audited Financial Results .... Regulatory Filings	2024-03-27	English
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Regulatory Filings	2024-03-24	English
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Regulatory Filings	2024-03-22	English
Declaration of Voting Results and Scrutinizer''s Report Regulatory Filings	2024-03-22	English
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Regulatory Filings	2024-03-19	English
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Regulatory Filings	2024-03-17	English
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Regulatory Filings	2024-03-13	English
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Regulatory Filings	2024-03-11	English
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Regulatory Filings	2024-03-05	English
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Regulatory Filings	2024-02-28	English
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Regulatory Filings	2024-02-27	English
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Regulatory Filings	2024-02-23	English
Intimation of Newspaper advertisement regarding completion of emailing of Notice of Postal Ballot to the Members Regulatory Filings	2024-02-21	English
Intimation regarding Newspaper Advertisement - Postal Ballot/ E-voting Regulatory Filings	2024-02-20	English
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Regulatory Filings	2024-02-20	English
Notice of Postal Ballot Proxy Solicitation & Information Statement	2024-02-20	English
Intimation of Newspaper advertisement regarding Postal Ballot/ E-voting Regulatory Filings	2024-02-18	English
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Regulatory Filings	2024-02-17	English
Appointment of Ms. Gira Sardesai (DIN: 02610502) as an Additional Director (Designated as Non-Executive and Independent Director) Regulatory Filings	2024-02-17	English
Cessation by virtue of completion of tenure of Mr. Jai Hiremath (DIN: 00062203) as an Independent Director Regulatory Filings	2024-02-17	English
Outcome of the meeting of the Board of Directors of Novartis India Limited held today i.e. Saturday, February 17, 2024 Regulatory Filings	2024-02-17	English
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Regulatory Filings	2024-02-09	English
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Regulatory Filings	2024-02-06	English
Intimation under Regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 Regulatory Filings	2024-01-30	English
Newspaper Publication regarding Unaudited Financial Results of the Company for the third quarter and nine months ended December 31, 2023 Regulatory Filings	2024-01-26	English
Resignation of Managing Director Regulatory Filings	2024-01-25	English
Financial Results for the third quarter and nine months ended December 31, 2023 Regulatory Filings	2024-01-25	English
Outcome of the Meeting of the Board of Directors of Novartis India Limited held today i.e. Thursday, January 25, 2024 Regulatory Filings	2024-01-25	English
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Regulatory Filings	2024-01-18	English
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Regulatory Filings	2024-01-16	English
Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018 Regulatory Filings	2024-01-12	English
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Regulatory Filings	2024-01-06	English
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Regulatory Filings	2024-01-02	English

Filings by year

2026 35 filings
2025 55 filings
2024 127 filings
2023 131 filings
2022 92 filings
2021 60 filings
2020 61 filings
2019 73 filings